SUSTAINED REDUCTION OF HBV ANTIGEN LEVELS DURING THE 8-WEEK FOLLOW-UP PERIOD IN TREATMENT NA&#207;VE (TN) OR CURRENTLY-NOT-TREATED (CNT) HBEAG-POSITIVE SUBJECTS WITH CHRONIC HEPATITIS B VIRUS INFECTION AFTER 96-WEEK 300 MG ALG-000184, WITH OR WITHOUT ENTECAVIR (ETV)

entecavir - Generic mfg.

ALG-000184 - Aligos Therap

https://journals.lww.com/hep/fulltext/2025/10001/the_liver_meeting__2025_abstracts.1.aspx

Man-Fung Yuen1; Edward Gane2; Kosh Agarwal3; Hong Ren4; Yanhua Ding5; Alina Jucov6; XieEr LIANG7; Jia Xu5; Alexei Haceatrean6; Kha Le8; Jennifer Rito8; Lawrence Blatt8; Sushmita Chanda8; Tse-I Lin8; Hardean E. Achneck8; Jinlin Hou7

Oct 8, 2025